For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| Philip Huang |
Philip Huang |
Lisa,Fu |
02-55696199 |
5F., No.54, Sec. 1, Zhongxiao E. Rd., Zhongzheng Dist.Taipei City, Taiwan |
2017/11/23 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
Healthconn is the innovated biomedical expert team with an integration of biotech, services and sales channels. Our core value is precision medicine which evaluates individual differences in genes, environment and lifestyle. We aim to provide clients with precision health solutions by collecting everyone’s physiological, environmental as well as lifestyle data and assessing those data to personal health promotions afterwards.
Moreover, by bringing advanced AI and IT techniques in US, Europe and Japan, Healthconn also supplies medical manufactures with world-class testing techniques of genes, biochips, food safety and environmental safety as well. In conclusion, to keep the world heathier, Healthconn provides individual client and business partners with not only high-end preventive healthcare but also appliance of the state-of-the-art AI and biotechnology. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
